1-20 of 27
Morio Matsumoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Alone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma or for Whom Transplant Is Not Planned As Initial Therapy: Analysis of Minimal Residual Disease in the Cepheus Trial

Sonja Zweegman, Thierry Facon, Vania Hungria, Nizar J. Bahlis, Christopher P. Venner, Marc Braunstein, Luděk Pour, Josep Marti Tutusaus, Supratik Basu, Yael C. Cohen, Morio Matsumoto, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Wojciech Maciej Legiec, Meral Beksac, Angelo Maiolino, Hiroyuki Takamatsu, Aurore Perrot, Mehmet Turgut, Weiping Liu, Jianping Wang, Katherine Chastain, Jessica Vermeulen, Maria Krevvata, Lorena Lopez-Masi, Jodi Carey, Melissa Rowe, Robin Carson, Saad Z. Usmani
Journal: Blood
Blood (2024) 144 (Supplement 1): 362.
https://doi.org/10.1182/blood-2024-200871
Published: 2024
Journal Articles

Impact of Long-Term Treatment with Belantamab Mafodotin on Safety and Efficacy Outcomes in Patients with Relapsed/Refractory Multiple Myeloma in DREAMM-3

Vania T.M Hungria, Katja Weisel, Atanas Radinoff, Sosana Delimpasi, Gabor Mikala, Tamas Masszi, Jian Li, Marcelo Capra, Angelo Maiolino, Vasiliki Pappa, Dominik Chraniuk, Iurii Osipov, Xavier Leleu, Michael Low, Morio Matsumoto, Mary Li, Neal Sule, Margaret Polinkovsky, Randy Davis, Shelley Bright, Astrid McKeown, Joanna Opalinska, Meletios Athanasios Dimopoulos
Journal: Blood
Blood (2023) 142 (Supplement 1): 3357.
https://doi.org/10.1182/blood-2023-178009
Published: 2023
Journal Articles

Prospective Comparison Study of Prognostic Value of MRD Detected By 8-Color MFC (EuroFlow-NGF) and NGS in Patients with Multiple Myeloma in ASCT Setting

Takeshi Yoroidaka, Hiroyuki Takamatsu, Mitsuhiro Itagaki, Satoshi Yoshihara, Kota Sato, Naoki Takezako, Shuji Ozaki, Kazuhito Suzuki, Kentaro Kohno, Morio Matsumoto, Yasushi Terasaki, Takeshi Yamashita, Shin-ichi Fuchida, Ryota Urushihara, Yuji Hiragori, Kenshi Suzuki, Hirokazu Murakami, Shinji Nakao, Brian G.M. Durie, Kazuyuki Shimizu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3946.
https://doi.org/10.1182/blood-2021-146441
Published: 2021
Journal Articles

Risk Factors for Central Nervous System (CNS) Relapse after Autologous Stem Cell Transplant (ASCT) in Diffuse Large B-Cell Lymphoma (DLBCL)

Yukie Terasaki, MD, Hiroaki Shimizu, MD PhD, Yuri Miyazawa, MD PhD, Kohtaro Toyama, MD PhD, Hiromi Koiso, MD PhD, Akihiko Yokohama, MD PhD, Morio Matsumoto, MD, Hidemi Ogura, Chiaki Naito, MD, Norifumi Tsukamoto, MD PhD, Hiroshi Handa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5344.
https://doi.org/10.1182/blood-2019-127990
Published: 2019
Journal Articles

Successful MPB Therapy Followed By Bortezomib Maintenance for Non-Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Japanese Phase 2 Study - Broad-J Study

Michihide Tokuhira, MD, Naoki Takezako, MD PhD, Yoichi Imai, MD PhD, Tadao Ishida, MD, Tomonori Nakazato, MD PhD, Kinuko Mitani, MD, PhD, Tohru Ikuta, MDPhD, Morio Matsumoto, MD, Takayuki Ikezoe, MD, PhD, Jun Taguchi, MD PhD, Kensuke Usuki, MD PhD, Takeshi Shimomura, MD, Kenkou Chin, MD, Shunya Arai, MD PhD, Kazuma Ohyashiki, MD, Miho Nara, MD, Kenji Kishi, MD, Yoshiaki Kuroda, MD, Yuichi Nakamura, MD, Hisashi Wakita, MD PhD, Makoto Sasaki, MD PhD, Hirotoshi Kamata, MD, Yoshikazu Ichikawa, MD, Akihiko Yokoyama, MD, Kenshi Suzuki, Masahiro Kizaki, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5432.
https://doi.org/10.1182/blood.V130.Suppl_1.5432.5432
Published: 2017
Journal Articles

The Role and Therapeutic Target of Base Excision Repair Genes in Multiple Myeloma (MM)

Rumi Ino, Takayuki Saitoh, MD PhDProf, Yuya Kitamura, Kazuki Homma, Noriyuki Takahashi, Gotoh Nanami, Master, Tetsuhiro Kasamatsu, PhD, Hiroaki Shimizu, MD PhD, Makiko Takizawa, PhDMD, Morio Matsumoto, MD, Morio Sawamura, MD PhD, Akihiko Yokohama, MD PhD, Norifumi Tsukamoto, MDPhDChief Division, Hiroshi Handa, MD PhDChief Division, Hirokazu Murakami, MDPhDProf
Journal: Blood
Blood (2017) 130 (Supplement 1): 4403.
https://doi.org/10.1182/blood.V130.Suppl_1.4403.4403
Published: 2017
Journal Articles

Cytogenetic Alterations Are Differently Associated with Disease Progression Depending on t(14;18) in Follicular Lymphoma

Akihiko Yokohama, MD PhD, Takeki Mitsui, MD PhD, Hiromi Koiso, MD PhD, Akio Saito, MD PhD, Kohtaro Toyama, MD PhD, Hiroaki Shimizu, MD PhD, Takuma Ishizaki, MD PhD, Yoko Hashimoto, MD PhD, Makiko Takizawa, PhDMD, Hiroyuki Irisawa, MD, Kayoko Murayama, MD PhD, Morio Matsumoto, MD, Takayuki Saito, MD PhDProf, Hiroshi Handa, MD PhDChief Division, Hirokazu Murakami, MDPhDProf, Norifumi Tsukamoto, MDPhDChief Division
Journal: Blood
Blood (2017) 130 (Supplement 1): 5136.
https://doi.org/10.1182/blood.V130.Suppl_1.5136.5136
Published: 2017
Journal Articles

Safety and Efficacy of Elotuzumab with Lenalidomide/Dexamethasone for Multiple Myeloma in a Japanese Subpopulation Analysis of the Phase 3 Eloquent-2 Trial

Kazuteru Ohashi, Kenshi Suzuki, MD PhD, Kazutaka Sunami, MD PhD, Shinsuke Iida, MD PhD, Shinichiro Okamoto, MD PhD, Hiroshi Handa, MD PhD, Kosei Matsue, MD PhD, Masafumi Miyoshi, Eric Bleickardt, MD, Morio Matsumoto, MD, Masafumi Taniwaki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3315.
https://doi.org/10.1182/blood.V128.22.3315.3315
Published: 2016
Journal Articles

Prognostic Value of Chromosomal Abnormalities for Follicular Lymphoma in the Rituximab-Era

Takeki Mitsui, MD PhD, Akihiko Yokohama, MD PhD, Hiromi Koiso, MD PhD, Akio Saito, MD PhD, Kohtaro Toyama, MD PhD, Hiroaki Shimizu, MD PhD, Takuma Ishizaki, MD PhD, Hiroyuki Irisawa, MD, Takayuki Saito, MD PhD, Kayoko Murayama, MD, Morio Matsumoto, MD, Hiroshi Handa, MD PhD, Hirokazu Murakami, MD PhD, Norifumi Tsukamoto, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1791.
https://doi.org/10.1182/blood.V128.22.1791.1791
Published: 2016
Journal Articles

Stem Cell Mobilization with High-Dose VP-16 Is Not Associated with an Increased Risk of Secondary MDS/AML after Autologous Transplant Against Malignant Lymphoma

Chiaki Naito, Hiroaki Shimizu, Yuri Miyazawa, Kohtaro Toyama, MD PhD, Takeki Mitsui, Hiromi Koiso, MD PhD, Hidemi Ogura, Morio Matsumoto, MD, Akihiko Yokohama, MD PhD, Norifumi Tsukamoto, MD PhD, Yoshihisa Nojima, Hiroshi Handa, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3445.
https://doi.org/10.1182/blood.V128.22.3445.3445
Published: 2016
Journal Articles

Retrospective Analysis of Prognostic Factors for Waldenström Macroglobulinemia: A Multicenter Cooperative Study in Japan

Akio Saito, MD PhD, Atsushi Isoda, MD PhD, Akihiko Yokohama, MD PhD, Hiroshi Handa, MD PhD, Norifumi Tsukamoto, MD PhD, Yutaka Tsukune, Makoto Sasaki, MD PhD, Morio Matsumoto, MD, Morio Sawamura, MDPhD, Shigeki Ito, MD PhD, Kohtaro Toyama, MD PhD, Michiaki Koike, Kayoko Murayama, MD, Asaka Onodera, MDPhD, Keiichi Moriya, MD PhD, Hideto Tamura, MD PhD, Hirotaka Nakahashi, MD PhD, Sakae Tanosaki, Toru Sakura, Masamitsu Karasawa, MD PhD, Masanori Iwashina, Masaru Kojima, MD PhD, Naoya Nakamura, MD PhD, Hirokazu Murakami, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5028.
https://doi.org/10.1182/blood.V126.23.5028.5028
Published: 2015
Journal Articles

Clinical Utility of Slam Family Member CD229 in Identifying Tumor Cells and High-Risk Disease Markers, CD86 (B7-2) and CD126 (IL-6 receptor), Using Flow Cytometric Analysis in Multiple Myeloma

Akiko Yamada, MD, Hideto Tamura, MD PhD, Mariko Ishibashi, PhD, Koiti Inokuchi, MD PhD, Makoto Sasaki, MD PhD, Yuriko Yahata, MD, Norio Komatsu, MD PhD, Atsushi Isoda, MD PhD, Morio Matsumoto, Hiroshi Handa, MD PhD, Yoichi Imai, MD PhD, Junji Tanaka, MD PhD, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD, Michiaki Koike, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2063.
https://doi.org/10.1182/blood.V124.21.2063.2063
Published: 2014
Journal Articles

Interaction Between B7-H1 Molecules on Myeloma Cells and PD-1 Molecules on T Cells Induces Resistance to Antimyeloma Chemotherapy

Mariko Ishibashi, PhD, Hideto Tamura, MD PhD, Mika Sunakawa, Asaka Kondo-Onodera, MD PhD, Keiichi Moriya, MD PhD, Namiko Okuyama, MD, Yasuko Hamada, MD, Atsushi Isoda, MD PhD, Morio Matsumoto, MD, Makoto Sasaki, MD PhD, Norio Komatsu, MD PhD, Hiroshi Handa, MD PhD, Yoichi Imai, MD PhD, Junji Tanaka, MD PhD, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD, Michiaki Koike, MD PhD, Koji Tamada, MD PhD, Koiti Inokuchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2018.
https://doi.org/10.1182/blood.V124.21.2018.2018
Published: 2014
Journal Articles

Soluble IL-2 Receptor α Is a More Sensitive Diagnostic Biomarker Than β2 Microglobulin and Predicts Survival in Follicular Lymphoma: Retrospective Analysis of 305 Cases

Akihiko Yokohama, MD, PhD, Yoko Hashimoto, MD PhD, Shimizu Hiroaki, MD PhD, Akio Saito, MD, Yuri Miyazawa, MD PhD, Hirono Iriujijima, MD PhD, Kotaro Toyama, MD PhD, Takuma Ishizaki, MD PhD, Takeki Mitsui, MD PhD, Hiromi Koiso, MD PhD, Makiko Takizawa, MD, PhD, Takayuki Saito, MD PhD, Hiroshi Handa, MD PhD, Kayoko Murayama, MD PhD, Morio Matsumoto, Morio Sawamura, MD PhD, Hirokazu Murakami, MD PhD, Yoshihisa Nojima, MD PhD, Junko Hirato, MD PhD, Masaru Kojima, MD PhD, Norifumi Tsukamoto, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3034.
https://doi.org/10.1182/blood.V124.21.3034.3034
Published: 2014
Journal Articles

Phase 2 Study of Lenalidomide in Combination with Low-Dose Dexamethasone in Japanese Transplantation-Ineligible Newly-Diagnosed Multiple Myeloma Patients

Takaaki Chou, Atsushi Shinagawa, MD PhD, Toshiki Uchida, MD, Masafumi Taniwaki, MD PhD, Hirokazu Hirata, MD PhD, Kenichi Ishizawa, MD PhD, Kosei Matsue, MD PhD, Yoshiaki Ogawa, MD, Takayuki Shimizu, MD PhD, Maki Otsuka, MD, Morio Matsumoto, MD, Shinsuke Iida, Yasuhito Terui, MD PhD, Itaru Matsumura, Takashi Ikeda, MD PhD, Naoki Takezako, MD PhD, Yumi Ogaki, MD, Shuichi Midorikawa, MD, Vanessa Houck, Annette Ervin-Haynes, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3452.
https://doi.org/10.1182/blood.V124.21.3452.3452
Published: 2014
Journal Articles

BCL6 Dose Not Negatively Regulate DNA Damage Response Genes in Multiple Myeloma Cells

Kenichi Tahara, MD, Makiko Takizawa, MD, PhD, Hiroshi Handa, MD, PhD, Yuta Masuda, Ayaka Kaneko, Itsumi Suda, Kei Kimura, Yuko Kuroda, Isoda Atsushi, MD, PhD, Morio Matsumoto, Hiromi Koiso, MD, PhD, Ishizaki Takuma, MD, PhD, Takeki Mitsui, MD, PhD, Akihiko Yokohama, MD, PhD, Takayuki Saitoh, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hirokazu Murakami, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 2035.
https://doi.org/10.1182/blood.V124.21.2035.2035
Published: 2014
Journal Articles

The Polymorphisms of Base Excision Repair Genes Influence the Prognosis of Multiple Myeloma

Chiaki Ushie, Takayuki Saitoh, M.D. Ph.D., Atsushi Iwasaki, Norihiko Moriyama, Hikaru Hattori, Morio Matsumoto, MD, Morio Sawamura, M.D. Ph.D., Jun Isoda, M.D. Ph.D., Hiroshi Handa, M.D. Ph.D., Akihiko Yokohama, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hatsue Ogawara, Ph.D., Hirokazu Murakami, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3981.
https://doi.org/10.1182/blood.V120.21.3981.3981
Published: 2012
Journal Articles

Possibility of Lenalidomide Therapy and Determination of Its Ideal Dose for Patients with Relapsed or Refractory Multiple Myeloma

Seiji Shida, MD, Naoto Takahashi, MD, PhD, FJSIM, Masatomo Miura, PhD, Takenori Niioka, PhD, Morio Matsumoto, MD, Masao Hagihara, MD, Mutsuhito Motegi, MD, PhD, Masaaki Kume, MD, PhD, Jun Kuroki, MD, PhD, Atsushi Kitabayashi, MD, PhD, Yoshiaki Hatano, MD, PhD, Atsushi Watanabe, MD, PhD, Naohito Fujishima, MD, PhD, Yoshihiro Kameoka, MD, PhD, Hiroyuki Tagawa, MD, PhD, Makoto Hirokawa, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4921.
https://doi.org/10.1182/blood.V120.21.4921.4921
Published: 2012
Journal Articles

Polymorphisms of IL-10, IL-17A, IL-17F and IL-18 Affect the Clinical Features of Multiple Myeloma in Japanese Patients

Atsushi Iwasaki, Takayuki Saitoh, M.D. Ph.D., Chiaki Ushie, Norihiko Moriyama, Tomonori Takani, Hikaru Hattori, Hiroshi Handa, M.D. Ph.D., Morio Matsumoto, MD, Jun Isoda, M.D. Ph.D., Morio Sawamura, M.D. Ph.D., Hatsue Ogawara, Ph.D., Hirokazu Murakami, M.D. Ph.D.
Journal: Blood
Blood (2012) 120 (21): 4972.
https://doi.org/10.1182/blood.V120.21.4972.4972
Published: 2012
Journal Articles

Dual functions of cell-autonomous and non–cell-autonomous ADAM10 activity in granulopoiesis

Brief Report
Masaki Yoda, Tokuhiro Kimura, Takahide Tohmonda, Shinichi Uchikawa, Takeshi Koba, Jiro Takito, Hideo Morioka, Morio Matsumoto, Daniel C. Link, Kazuhiro Chiba, Yasunori Okada, Yoshiaki Toyama, Keisuke Horiuchi
Journal: Blood
Blood (2011) 118 (26): 6939–6942.
https://doi.org/10.1182/blood-2011-06-357210
Published: 2011
Includes: Supplemental data